Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26,212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Values of Baseline Posterior Circulation Acute Stroke Prognosis Early Computed Tomography Score for Treatment Decision of Acute Basilar Artery Occlusion.
Sang H, Li F, Yuan J, Liu S, Luo W, Wen C, Zhu Q, Chen W, Lin M, Qi L, Zhong Y, Wang Z, Ling W, Shi Z, Chen H, Liu W, Liu Z, Yao X, Xiong F, Zeng G, Hu X, Dong H, Mao A, Yang G, Huang J, Chen L, Gong Z, Tao J, Liu H, Wu D, Qiu Z, Yang Q, Zi W, Li F. Sang H, et al. Among authors: mao a. Stroke. 2021 Mar;52(3):811-820. doi: 10.1161/STROKEAHA.120.031371. Epub 2021 Feb 11. Stroke. 2021. PMID: 33567874
Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
Sang H, Huang J, Jiang B, Guo Q, Nguyen TN, Abdalkader M, Han Q, Zhou S, Tao Z, Mao A, Yan Z, Du J, Jin Y, Huang C, Liu T, Zhao W, Gu G, Wang L, Liu S, Luo S, Pu J, Hu J, Yang J, Li F, Zi W, Hu X, Qiu Z. Sang H, et al. Among authors: mao a. J Neurol. 2023 Apr;270(4):2246-2255. doi: 10.1007/s00415-023-11579-4. Epub 2023 Jan 25. J Neurol. 2023. PMID: 36697890 Clinical Trial.
Intravenous Tirofiban Versus Alteplase Before Endovascular Treatment in Acute Ischemic Stroke: A Pooled Analysis of the DEVT and RESCUE BT Trials.
Sang H, Cao Z, Du J, Nguyen TN, Saver JL, Mao A, Nogueira RG, Tao Z, Zhou S, Han Q, Sun D, Lei B, Liu S, Zeng G, Yin C, Xie D, Luo W, Jin Z, Qiu Z; DEVT and RESCUE BT Trial Investigators. Sang H, et al. Among authors: mao a. Stroke. 2024 Apr;55(4):856-865. doi: 10.1161/STROKEAHA.123.044562. Epub 2024 Feb 16. Stroke. 2024. PMID: 38362756
Comprehensive safety evaluation of a novel multitargeting compound XYY-CP1106: A candidate for Alzheimer's disease.
Fan M, Song X, Lu L, He J, Shen Y, Zhang C, Wang F, Xie Y. Fan M, et al. Biomed Pharmacother. 2024 May 27;176:116786. doi: 10.1016/j.biopha.2024.116786. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38805971
Here, the safety evaluation of a novel multi-targeted candidate in AD (XYY-CP1106), characterized by its dual-property of iron chelation and monoamine oxidase B inhibition, was conducted by multifaceted analysis. ...
Here, the safety evaluation of a novel multi-targeted candidate in AD (XYY-CP1106), characterized by its dual-property of iron chelation and …
Neurotoxic effects of carbamazepine on the mosquitofish Gambusia affinis.
Nikhil J, Maneesha P, Chitra KC. Nikhil J, et al. Drug Chem Toxicol. 2024 May 28:1-15. doi: 10.1080/01480545.2024.2356048. Online ahead of print. Drug Chem Toxicol. 2024. PMID: 38804213
Furthermore, the neurotoxic effects of carbamazepine were clearly demonstrated through alterations in various neurological parameters, including acetylcholinesterase, dopamine, gamma-aminobutyric acid, serotonin, monoamine oxidase, 5-hydroxyindole acetic acid, adren …
Furthermore, the neurotoxic effects of carbamazepine were clearly demonstrated through alterations in various neurological parameters, inclu …
Identification and optimization of nitrophenolic analogues as dopamine metabolic enzyme inhibitors for the treatment of Parkinson's disease.
Zou M, Wu Y, Lan Y, Xie H, Sun H, Liu W, Feng F, Jiang X. Zou M, et al. Bioorg Chem. 2024 May 23;148:107488. doi: 10.1016/j.bioorg.2024.107488. Online ahead of print. Bioorg Chem. 2024. PMID: 38797066
Simultaneous inhibition of the two key dopamine metabolic enzymes, catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAO-B), could potentially be a breakthrough in achieving clinical efficacy. ...
Simultaneous inhibition of the two key dopamine metabolic enzymes, catechol-O-methyltransferase (COMT) and monoamine oxidase B …
26,212 results
You have reached the last available page of results. Please see the User Guide for more information.